Article
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis.
Neoplasia (New York, N.Y.) - 1 Oct 2022
Talvitie Eva-Maria, Liljeroos Lassi, Vilhonen Heikki, Orte Katri, Leivo Ilmo, Kallajoki Markku, Taimen Pekka
Abstract excerpt
INTRODUCTION: Lung adenocarcinoma is the most common type of lung cancer and typically carries a high number of mutations. However, the genetic background of the tumors varies according to patients' ethnic background and smoking status. Little data is available on the mutational landscape and the frequency of actionable genomic alterations in lung adenocarcinoma in the Finnish population. MATERIALS AND METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
